Mohsen Saravani

489 total citations
41 papers, 366 citations indexed

About

Mohsen Saravani is a scholar working on Molecular Biology, Cancer Research and Obstetrics and Gynecology. According to data from OpenAlex, Mohsen Saravani has authored 41 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Cancer Research and 11 papers in Obstetrics and Gynecology. Recurrent topics in Mohsen Saravani's work include Pregnancy and preeclampsia studies (10 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (5 papers). Mohsen Saravani is often cited by papers focused on Pregnancy and preeclampsia studies (10 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (5 papers). Mohsen Saravani collaborates with scholars based in Iran and Tunisia. Mohsen Saravani's co-authors include Saeedeh Salimi, Alireza Nakhaee, Azim Akbarzadeh, Mohammad Bokaeian, Ali Akbar Farhangi, Farzaneh Farajian‐Mashhadi, Minoo Yaghmaei, Anoosh Naghavi, Mohsen Rokni and Mohammad Hadi Nematollahi and has published in prestigious journals such as SHILAP Revista de lepidopterología, BioMed Research International and IUBMB Life.

In The Last Decade

Mohsen Saravani

33 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohsen Saravani Iran 12 115 102 91 55 49 41 366
Jue Tian China 15 254 2.2× 39 0.4× 88 1.0× 75 1.4× 26 0.5× 24 496
Thierry Ntimbane Canada 9 231 2.0× 85 0.8× 110 1.2× 30 0.5× 41 0.8× 10 567
Mi Lai China 11 107 0.9× 82 0.8× 51 0.6× 14 0.3× 37 0.8× 13 345
Andrzej Zieleniak Poland 9 139 1.2× 80 0.8× 42 0.5× 23 0.4× 28 0.6× 19 288
Stepan B. Melnyk United States 16 195 1.7× 29 0.3× 49 0.5× 54 1.0× 11 0.2× 25 551
Ana Mompeón Spain 10 164 1.4× 21 0.2× 120 1.3× 31 0.6× 77 1.6× 18 383
Syeda H Afroze United States 11 133 1.2× 44 0.4× 45 0.5× 25 0.5× 31 0.6× 23 419
Shinichi Abe Japan 13 117 1.0× 79 0.8× 9 0.1× 43 0.8× 59 1.2× 38 459
Caterina Formichi Italy 17 275 2.4× 71 0.7× 216 2.4× 65 1.2× 219 4.5× 27 731
Marzena Dworacka Poland 13 130 1.1× 32 0.3× 35 0.4× 108 2.0× 129 2.6× 40 485

Countries citing papers authored by Mohsen Saravani

Since Specialization
Citations

This map shows the geographic impact of Mohsen Saravani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohsen Saravani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohsen Saravani more than expected).

Fields of papers citing papers by Mohsen Saravani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohsen Saravani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohsen Saravani. The network helps show where Mohsen Saravani may publish in the future.

Co-authorship network of co-authors of Mohsen Saravani

This figure shows the co-authorship network connecting the top 25 collaborators of Mohsen Saravani. A scholar is included among the top collaborators of Mohsen Saravani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohsen Saravani. Mohsen Saravani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saravani, Mohsen, et al.. (2025). Evaluation of the serum level of CTRP-3 and CTRP-6 in patients with Hashimoto’s disease and correlation with thyroid hormones and lipid profile. Journal of Basic and Clinical Physiology and Pharmacology. 36(1). 61–67.
5.
Saravani, Mohsen, et al.. (2024). Metformin's impact on asprosin and FBN1 expression: Potential mechanisms beyond insulin sensitivity in type 2 diabetes in rats. SHILAP Revista de lepidopterología. 8. 100207–100207. 1 indexed citations
6.
Salimi, Saeedeh, Majid Zaki‐Dizaji, Arman Shafiee, et al.. (2023). Impact of Survivin rs9904341 and rs17878467 Polymorphisms On Risk of Preeclampsia in Iran. Biochemical Genetics. 62(3). 2134–2147.
8.
Saravani, Mohsen, et al.. (2023). Maternal and Placental ANRIL Polymorphisms and Preeclampsia Susceptibility. Personalized Medicine. 20(5). 445–452. 1 indexed citations
9.
Sargazi, Saman, et al.. (2021). Relationship between miR-143/145 cluster variations and cancer risk: proof from a Meta-analysis. Nucleosides Nucleotides & Nucleic Acids. 40(5). 578–591. 20 indexed citations
10.
Salimi, Saeedeh, et al.. (2021). Association of IL‐1β, NLRP3, and COX‐2 Gene Polymorphisms with Autoimmune Thyroid Disease Risk and Clinical Features in the Iranian Population. BioMed Research International. 2021(1). 7729238–7729238. 14 indexed citations
11.
Sandoughi, Mahnaz, et al.. (2020). The Impact of TRAIL (C1595T and G1525A) and DR4 (rs20576) Gene Polymorphisms on Systemic Lupus Erythematosus. Biochemical Genetics. 58(4). 649–659. 4 indexed citations
12.
Sandoughi, Mahnaz, et al.. (2020). Association between COX‐2 and 15‐PGDH polymorphisms and SLE susceptibility. International Journal of Rheumatic Diseases. 23(5). 627–632. 12 indexed citations
13.
Saravani, Mohsen, et al.. (2020). Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development. IUBMB Life. 72(12). 2601–2610. 6 indexed citations
14.
Salimi, Saeedeh, et al.. (2020). Association of H19 rs3741219 polymorphism with the susceptibility to uterine leiomyomas. Gene Reports. 19. 100623–100623. 3 indexed citations
15.
Saravani, Mohsen, et al.. (2020). Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk. Molecular Biology Reports. 47(5). 3551–3556. 10 indexed citations
16.
Saravani, Mohsen, Mohsen Rokni, Mehrzad Mehrbani, et al.. (2019). The evaluation of VEGF and HIF‐1α gene polymorphisms and multiple sclerosis susceptibility. The Journal of Gene Medicine. 21(12). e3132–e3132. 20 indexed citations
17.
Jahantigh, Danial, et al.. (2019). Impact of HOTAIR variants on preeclampsia susceptibility based on blood and placenta and in silico analysis. IUBMB Life. 71(9). 1367–1381. 22 indexed citations
18.
Saravani, Mohsen, et al.. (2019). Association of HOTAIR gene polymorphisms and haplotypes with uterine leiomyoma susceptibility in southeast of Iran. Molecular Biology Reports. 46(4). 4271–4277. 7 indexed citations
19.
Rokni, Mohsen, et al.. (2018). Association between miRNA-152 polymorphism and risk of preeclampsia susceptibility. Archives of Gynecology and Obstetrics. 299(2). 475–480. 13 indexed citations
20.
Salimi, Saeedeh, Mohsen Saravani, Minoo Yaghmaei, et al.. (2014). The early-onset preeclampsia is associated with MTHFR and FVL polymorphisms. Archives of Gynecology and Obstetrics. 291(6). 1303–1312. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026